Patents by Inventor Daniel Inderbitzin

Daniel Inderbitzin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
    Patent number: 6828145
    Abstract: Disclosed herein is the discovery that mammalian stem cells do not express &bgr;2microglobulin (&bgr;2m). The invention discloses a method of isolating stem cells comprising sorting, from a sample of cells, cells that express &bgr;2m from cells that do not express &bgr;2m. One then selects stem cells from the population of cells that does not express &bgr;2m. This is accomplished by selecting cells that express a known marker, such as proteins expressed by genes encoding the major histocompatibility complex. An isolated stem cell is disclosed, as is a method for identifying it and other stem cells.
    Type: Grant
    Filed: May 9, 2001
    Date of Patent: December 7, 2004
    Assignee: Cedars-Sinai Medical Center
    Inventors: Itzhak Avital, Walid Arnaout, Daniel Inderbitzin